Nikki Nogal, PhD
Global Director, Technical & CMC at Lonza
Dr. Nogal brings more than twenty years of experience in pre-discovery through the lifecycle management of mature products, leading CMC projects that contrasted from “fast to market” or “quick to clinic.” Through this time, she has gained an impressive understanding of process development and commercial manufacturing at various companies including Gilead and Genentech/Roche. Most recently, as the Head of Process Development at Abzena, Dr. Nogal oversaw the process development strategy and leveraged her extensive experience in helping clients execute on grants and contracts for the production of biopharmaceuticals (API, mAbs, vaccines, therapeutic proteins, and enzymes). In her current role as the Global Director of Technical and CMC at Lonza AG, she provides scientific, technical, and CMC leadership with Sales, Proposal, and Operational teams for on-time delivery of IND program milestones.
Dr. Nogal graduated with BS and MS degrees in Chemical Engineering from the University of Maryland and her PhD in Biomedical Engineering from Florida State University. She completed postdoctoral training at Johnson & Johnson, and the University of California San Diego in Pharmacology and Bioengineering.